✦ LIBER ✦

Safety profile of oral and intravenous moxifloxacin: Cumulative data from clinical trials and postmarketing studies

✍ Scribed by Peter Ball; Ralf Stahlmann; Rolf Kubin; Shurjeel Choudhri; Robert Owens

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of drotrecogin alfa (activated) i

✍ Brad Woodward; Martina Cartwright 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Ensuring safety, implementation and scie

✍ Redonna K. Chandler; Michael L. Dennis; Nabila El-Bassel; Robert P. Schwartz; Ga 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 284 KB

Efficacy of intravenous citalopram compa

✍ J.D Guelfi; N Strub; H Loft 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Critical review of oral drug treatments

✍ Hugo Adriaensen; Léon Plaghki; Chantal Mathieu; Alfred Joffroy; Kris Vissers 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Lipid-altering efficacy and safety profi

✍ L. A. Leiter; D. J. Betteridge; M. Farnier; J. R. Guyton; J. Lin; A. Shah; A. O. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB